Angiographic outcomes of everolimus eluting stent (PtCr-EES) compared to zotarolimus-eluting stent (Resolute) implantation for stent restenosis lesions in patients with coronary artery disease.

Trial Profile

Angiographic outcomes of everolimus eluting stent (PtCr-EES) compared to zotarolimus-eluting stent (Resolute) implantation for stent restenosis lesions in patients with coronary artery disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Everolimus (Primary) ; Zotarolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top